In contrast to that, most of the cytokines which are assumed to promote tumor development are anti-inflammatory cytokines, as for example IL-10 or TGF-β, indicating that IL-17A might be important for tumor rejection (Wang et al., 2009; Chen et al., 2010). The gene discussed is IL10; the disease is neoplasm.